Clustering according to urolithin metabotype explains the interindividual variability in the improvement of cardiovascular risk biomarkers in overweight-obese individuals consuming pomegranate: A randomized clinical trial.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

The pomegranate lipid-lowering properties remain controversial, probably due to the interindividual variability in polyphenol (ellagitannins) metabolism.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Mol Nutr Food Res

Title: Molecular nutrition & food research

Publisher: Wiley-Blackwell

ISSN (Electronic): 1613-4133

ISSN (Print): 1613-4125

Publication date (Electronic): May 2017

Volume: 61

Issue: 5

Affiliations

[1 ] Department of Food Science and Technology, Research Group on Quality, Safety and Bioactivity of Plant Foods, CEBAS-CSIC, Murcia, Spain.

[2 ] TÜBİTAK Marmara Research Center, Food Institute, Gebze-Kocaeli, Turkey.

[3 ] Department of Biochemistry, Faculty of Medicine, , Karadeniz Technical University, Trabzon, Turkey.

[4 ] Department of Food Technology and Nutrition, Catholic University of San Antonio, Murcia, Spain.

Article

DOI: 10.1002/mnfr.201600830

PubMed ID: 27879044

SO-VID: eb37c50d-c099-4b0d-b87a-3e5479ad4634

History

Keywords: Cardiometabolic,EFSA,Gut microbiota,Metabotype,Urolithins

Data availability:

Keywords: Cardiometabolic, EFSA, Gut microbiota, Metabotype, Urolithins

Comments

Comment on this article

scite_

Cited by 78

See all cited by